Related references
Note: Only part of the references are listed.Dengue vaccines: progress and challenges
Beth-Ann G. Coller et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Silica Crystals and Aluminum Salts Regulate the Production of Prostaglandin in Macrophages via NALP3 Inflammasome-Independent Mechanisms
Etsushi Kuroda et al.
IMMUNITY (2011)
An Unexpected Role for Uric Acid as an Inducer of T Helper 2 Cell Immunity to Inhaled Antigens and Inflammatory Mediator of Allergic Asthma
Mirjam Kool et al.
IMMUNITY (2011)
Helios Is Associated with CD4 T Cells Differentiating to T Helper 2 and Follicular Helper T Cells In Vivo Independently of Foxp3 Expression
Karine Serre et al.
PLOS ONE (2011)
A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses
Chen-Yi Chiang et al.
PLOS ONE (2011)
The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in mice
Lidice Bernardo et al.
VACCINE (2011)
Next generation dengue vaccines: A review of candidates in preclinical development
Julia Schmitz et al.
VACCINE (2011)
Domain III of the envelope protein as a dengue vaccine target
Maria G. Guzman et al.
EXPERT REVIEW OF VACCINES (2010)
A recombinant lipoprotein containing an unsaturated fatty acid activates NF-κB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide
Chih-Hsiang Leng et al.
MOLECULAR IMMUNOLOGY (2010)
Dengue: a continuing global threat
Maria G. Guzman et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Emulsified Nanoparticles Containing Inactivated Influenza Virus and CpG Oligodeoxynucleotides Critically Influences the Host Immune Responses in Mice
Ming-Hsi Huang et al.
PLOS ONE (2010)
A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
Olivia K. T. Block et al.
VACCINE (2010)
Formulation and Immunological Evaluation of Novel Vaccine Delivery Systems Based on Bioresorbable Poly(ethylene glycol)-block-poly(lactide-co-ε-caprolactone)
Ming-Hsi Huang et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2009)
A Protective Role for Dengue Virus-Specific CD8+ T Cells
Lauren E. Yauch et al.
JOURNAL OF IMMUNOLOGY (2009)
Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine
Ming-Hsi Huang et al.
MICROBES AND INFECTION (2009)
A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity
Chih-Hsiang Leng et al.
MICROBES AND INFECTION (2009)
Development of Multi-Phase Emulsions Based on Bioresorbable Polymers and Oily Adjuvant
Ming-Hsi Huang et al.
PHARMACEUTICAL RESEARCH (2009)
A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design
Hsin-Wei Chen et al.
VACCINE (2009)
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice
Iris Valdes et al.
VIROLOGY (2009)
Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates
Lidice Bernard et al.
ANTIVIRAL RESEARCH (2008)
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Mirjam Kool et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner
Erin Mehlhop et al.
CELL HOST & MICROBE (2007)
Prospects for a dengue virus vaccine
Stephen S. Whitehead et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice
Aida Zulueta et al.
VIRUS RESEARCH (2006)
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein Vaccines in rhesus macaques
Monika Simmons et al.
JOURNAL OF VIROLOGY (2006)
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
JR Putnak et al.
VACCINE (2005)
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, Whereas T- and B-cell-dependent immunity are less critical
S Shresta et al.
JOURNAL OF VIROLOGY (2004)
An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells
JJ Hung et al.
JOURNAL OF VIROLOGY (2004)
Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes:: insight into the neutralization mechanism
P Thullier et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
WD Crill et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
